#USA #Inc. #food-as-medicine #Epicured #Glen Cove

Epicured Joins the Inc. 5000 Ranks

Epicured, a pioneering food-as-medicine company, has recently made headlines by being ranked No. 1595 on the prestigious 2026 Inc. 5000 list, which recognizes the fastest-growing private companies across the United States. This accolade is a testament to the company’s impressive 219% revenue growth over three years, positioning it as the 128th fastest-growing firm in New York and the 168th in the healthcare category.

Founded in 2016, Epicured originally set out to cater to individuals managing gastrointestinal disorders such as IBS and celiac disease. As it evolved, the company broadened its vision to address a wide range of chronic conditions including diabetes and cardiovascular diseases. Epicured has become a significant player in the realm of medically tailored nutrition, combining the expertise of healthcare professionals to create flavorful meals that meet stringent clinical guidelines.

In a market where nutritious food is often inaccessible or unappealing to those with dietary restrictions, Epicured has tackled this challenge head-on. By fusing clinical evidence with gourmet culinary practices, they have made healthy eating enjoyable, ensuring customers no longer have to compromise on taste while addressing their medical needs. The company’s meals, crafted by expert chefs, offer an enticing solution to dietary challenges that many face daily.

Epicured has not only expanded its direct-to-consumer meal delivery service but has also made significant strides into commercial healthcare sectors. The company collaborates with social care networks to provide specifically designed meal plans, grocery options, and nutritional counseling, particularly benefiting Medicaid beneficiaries in New York. These initiatives are part of New York's $7.5 billion Section 1115 Waiver, aimed at enhancing health outcomes for underserved populations. Additionally, they have partnered with PACE programs in Massachusetts to support elderly nutrition.

Moreover, Epicured has ventured into the world of performance nutrition, becoming the nutrition partner for professional sports teams, ensuring elite athletes receive the best possible nutrition to enhance their performance. The company has also established a Life Sciences Division, contributing to pharmaceutical research by supporting clinical trials for metabolic and gastrointestinal diseases.

According to Richard Bennett, co-founder and CEO of Epicured, the recognition from Inc. 5000 is an honor that reflects the company's commitment to revolutionizing health through proper nutrition. He expressed that the journey was guided by a vision to provide accessible, effective nutrition solutions that directly influence health outcomes.

To support its rapid expansion and meet increasing demand, Epicured recently opened a 30,000 square-foot production facility on Staten Island, which significantly boosts their production capacity. Plans are also in the works for another facility on the West Coast, aiming to fortify their national presence and operational efficiency.

The Inc. 5000 list criteria include ranking companies based on revenue growth from 2022 to 2025, with a requirement for a minimum revenue of $100,000 in 2022 and $2 million in 2025. Epicured’s achievement not only highlights its rapid growth trajectory but also emphasizes the rising recognition of food as an integral component of healthcare.

As the company continues to push boundaries in nutritional science and expand its service offerings, it clearly demonstrates that in today’s healthcare landscape, affordable, delicious meal solutions can indeed play a pivotal role in managing chronic diseases and promoting overall well-being.

To explore further about Epicured and its initiatives, visit Epicured's website or follow them on LinkedIn for updates on their innovative approaches to nutrition and health.